Learn More About This New FDA Approved Treatment for Schizophrenia

Schizophrenia is a complex and chronic brain disorder affecting approximately 2.8 million adults in the US. Dr. Gustavo Alva, Medical Director at ATP Clinical Research (Gus Alva MD – ATP Clinical Research) and Patrick, an adult living with schizophrenia have information about a new FDA approved treatment.
Share on facebook
Share on google
Share on twitter
Share on linkedin

latest TV episodes

Shopping Basket

SIGN UP TO RECEIVE THE LATEST UPDATES FROM TALK! WITH AUDREY

Subscribe to
TALK! with AUDREY's Newsletter

FOLLOW US ON SOCIAL!